drugset / Trial / NCT01002183
Fosmidomycin With Clindamycin or With Clindamycin Plus Artesunate
Phase 2
Withdrawn
40 enrolled
Jomaa Pharma GmbH
Mahidol University · collabThammasat University · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The aim of this study is to evaluate the role of clindamycin and artesunate as possible combination partners for fosmidomycin to protect it from its susceptibility to recrudescent infections when used as monotherapy for acute Plasmodium falciparum malaria while retaining its excellent safety profile
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Outcome
Outcome not reported
Stopped: “Drug combination is no longer pursued”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fosmidomycin | Small molecule | 450 mg | — |